VOYA Investment Management’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-24,252
| Closed | -$3.67M | – | 2991 |
|
2022
Q3 | $3.67M | Buy |
24,252
+693
| +3% | +$105K | ﹤0.01% | 1075 |
|
2022
Q2 | $3.43M | Sell |
23,559
-46,743
| -66% | -$6.81M | 0.01% | 890 |
|
2022
Q1 | $8.34M | Buy |
70,302
+20,898
| +42% | +$2.48M | 0.02% | 683 |
|
2021
Q4 | $6.81M | Sell |
49,404
-82,875
| -63% | -$11.4M | 0.01% | 733 |
|
2021
Q3 | $18.4M | Sell |
132,279
-50,588
| -28% | -$7.03M | 0.04% | 358 |
|
2021
Q2 | $17.8M | Sell |
182,867
-27,273
| -13% | -$2.65M | 0.03% | 388 |
|
2021
Q1 | $14.4M | Buy |
210,140
+29,097
| +16% | +$1.99M | 0.03% | 453 |
|
2020
Q4 | $15.5M | Sell |
181,043
-24,395
| -12% | -$2.09M | 0.03% | 415 |
|
2020
Q3 | $13.4M | Sell |
205,438
-2,024
| -1% | -$132K | 0.03% | 440 |
|
2020
Q2 | $15.2M | Sell |
207,462
-87,196
| -30% | -$6.37M | 0.04% | 406 |
|
2020
Q1 | $10M | Buy |
294,658
+20,110
| +7% | +$684K | 0.03% | 485 |
|
2019
Q4 | $14.9M | Sell |
274,548
-139,032
| -34% | -$7.57M | 0.03% | 479 |
|
2019
Q3 | $17.3M | Buy |
413,580
+157,079
| +61% | +$6.55M | 0.04% | 429 |
|
2019
Q2 | $11.2M | Buy |
256,501
+244,175
| +1,981% | +$10.7M | 0.02% | 570 |
|
2019
Q1 | $634K | Buy |
12,326
+351
| +3% | +$18.1K | ﹤0.01% | 1637 |
|
2018
Q4 | $443K | Sell |
11,975
-260
| -2% | -$9.62K | ﹤0.01% | 1802 |
|
2018
Q3 | $459K | Sell |
12,235
-620
| -5% | -$23.3K | ﹤0.01% | 1890 |
|
2018
Q2 | $508K | Sell |
12,855
-602
| -4% | -$23.8K | ﹤0.01% | 1821 |
|
2018
Q1 | $347K | Buy |
+13,457
| New | +$347K | ﹤0.01% | 2022 |
|